Department of Radiation Oncology, The Methodist Hospital & Research Institute, Houston, TX, USA.
The Methodist Hospital Cancer Center, 6565 Fannin, Ste#DB1-077, Houston, Texas 77030, USA.
Stereotactic body radiation therapy (SBRT) is a promising treatment option for prostate cancer. Hypofractionation regimens, such as SBRT, may be more advantageous compared with conventional regimens because low α:β ratio of prostate cancer has high sensitivity to dose per fraction. In addition, a smaller and tighter margin with SBRT is expected to provide a low toxicity rate without reducing tumor control. The purpose of this article is to examine radiobiological, technical and clinical aspects of SBRT for prostate cancer.
Written by:
Ishiyama H, Teh BS, Lo SS, Mathews T, Blanco A, Amato R, Ellis RJ, Mayr NA, Paulino AC, Xu B, Butler BE. Are you the author?
Reference: Future Oncol. 2011 Sep;7(9):1077-86.
doi: 10.2217/fon.11.86
PubMed Abstract
PMID: 21919695
UroToday.com Prostate Cancer Section
